Scaling up COVID-19 rapid antigen tests: promises and challenges

WHO recommends a minimum of 80% sensitivity and 97% specificity for antigen-detection rapid diagnostic tests (Ag-RDTs), which can be used for patients with symptoms consistent with COVID-19. However, after the acute phase when viral load decreases, use of Ag-RDTs might lead to high rates of false ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Peeling, Rosanna W, Olliaro, Piero L, Boeras, Debrah I, Fongwen, Noah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Personal View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906660/
https://www.ncbi.nlm.nih.gov/pubmed/33636148
http://dx.doi.org/10.1016/S1473-3099(21)00048-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906660/
https://www.ncbi.nlm.nih.gov/pubmed/33636148
http://dx.doi.org/10.1016/S1473-3099(21)00048-7

Ejemplares similares